Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study

Neurology

Volumn 56, Issue 12, 2001, Pages 1683-1689

  Kivipelto, Miia ^a   Helkala, E L ^a   Hanninen T ^a   Laakso, M P ^b   Hallikainen, M ^a,b   Alhainen, K ^c   Soininen, H ^a,b   Tuomilehto, J ^d   Nissinen, A ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c NORTH KARELIA CENTRAL HOSPITAL   (Finland)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; COGNITIVE DEFECT; FEMALE; HUMAN; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

EID: 0035954333     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.56.12.1683     Document Type: Article

References (35)

1. Mild cognitive impairment
2. Are cognitive function and blood pressure related?
3. Risk factors for vascular disease and dementia
4. 15-Year longitudinal study of blood pressure and dementia
5. Midlife blood pressure and dementia: The Honolulu-Asia Aging Study
6. Elevated systolic blood pressure and high cholesterol levels at midlife are risk factors for late-life dementia
7. The association between midlife blood pressure levels and late-life cognitive function
8. Hypertension is related to cognitive impairment; a 20-year follow-up of 999 men
9. Untreated blood pressure level is inversely related to cognitive functioning: The Framingham Study
10. Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins
11. Current and remote blood pressure and cognitive decline
12. Serum total cholesterol, apolipoprotein E 4, and Alzheimer's disease
13. Neuropathology of Alzheimer's disease: What is new since A. Alzheimer?
14. Definition, course, and outcome of mild cognitive impairment
15. Apolipoprotein E status as a predictor of development of Alzheimer's disease in memory-impaired individuals
16. Twenty-year trends in coronary risk factors in North-Karelia and in other areas of Finland
17. "Mini-Mental State": A practical method for grading the cognitive state of patients for the clinician
18. Evaluating storage, retention, and retrieval in disordered memory and learning
19. Word fluency and brain damage
20. A modified card sorting test sensitive to frontal lobe defects
21. Validity of the Trail Making Test as an indicator of organic brain damage
22. Clinical Dementia Rating (CDR)
23. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
24. Nonresponse pattern and bias in a community-based cross-sectional study of cognitive functioning among the elderly
25. Vascular factors and Alzheimer disease
26. Midlife cardiovascular risk factors and brain morphology in identical older male twins
27. Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms
28. Cholesterol modulates α-secretase cleavage of amyloid precursor protein
29. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons
30. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset